How often do you take AOD 9604? Most research protocols use one daily injection of 300–600 mcg, though timing and frequency vary by goal and study design.
AOD 9604 is usually taken once per day as a single subcutaneous injection of 300 mcg to 600 mcg. Some protocols split that total into two smaller doses, one in the morning and one in the evening, but once-daily dosing is the standard in the research literature. AOD 9604 is not FDA-approved for human use in the United States, so every schedule you see online comes from research protocols or user reports rather than a regulator-approved label.
The short answer is simple, but the details — timing, total dose, and cycle length — are what most people actually want to know. Here is how the common schedules break down.
Why Once-Daily Dosing Is the Default
AOD 9604 is a synthetic fragment of human growth hormone, specifically amino acids 176 through 191. That fragment is the portion of hGH linked to fat breakdown rather than growth or blood sugar effects.
It was selected for research partly because its half-life is short, roughly 20 to 30 minutes, and it does not meaningfully raise IGF-1 the way full growth hormone does. The metabolic signal it triggers appears to last longer than the peptide itself stays in the bloodstream, which is the main reason frequent injections are not considered necessary.
Once-daily use also matches how the compound was dosed in most human trials, and simplicity matters when a protocol runs for weeks at a time.
Typical AOD 9604 Injection Schedules
Most protocols fit into a handful of patterns. The doses below reflect research summaries and community reporting, not an approved product label.
| Schedule | Total daily dose | Injections per day | Typical timing |
|---|---|---|---|
| Once daily (standard) | 300 mcg | 1 | Morning, fasted |
| Once daily (higher dose) | 500–600 mcg | 1 | Morning, fasted |
| Split dose | 300–600 mcg total | 2 | Morning and pre-bed |
| Weekday protocol | 300 mcg | 1 | Five days on, two days off |
| Cycled protocol | 300–600 mcg | 1 | 8–12 weeks on, then a break |
Reconstitution math trips up more people than the dosing itself. A 5 mg vial mixed with 1 mL of bacteriostatic water contains 5,000 mcg per mL, so a 300 mcg dose equals 6 units on a U-100 insulin syringe. Charts labeled aod-9604 5mg dosage vary from vendor to vendor, so confirm how your specific vial was mixed before drawing anything.
Morning vs. Evening, Fasted vs. Fed
Most people inject in the morning on an empty stomach and wait 30 to 60 minutes before eating. The reasoning is that insulin and dietary fat may blunt the fat-mobilizing signal the peptide is meant to trigger.
Evening injections before bed are also common, especially in split-dose protocols. No head-to-head study has shown that one window is clearly better than the other, and the difference is probably small compared with consistency.
People who also use growth hormone often research the best time to take hgh, and the same principles tend to carry over: fasted, at the same time each day, and away from large meals.
Cycle Length and What the Research Shows
Clinical studies of AOD 9604 have generally run for about 12 weeks. Community protocols often mirror that length, though some people extend to 16 or 24 weeks and others cycle 8 weeks on with 4 weeks off.
The trial results themselves have been mixed. Some early studies reported modest fat loss at higher daily doses, while larger and later trials did not produce the dramatic changes that marketing materials often suggest. Trials also used a wide dose range, from roughly 300 mcg up to 1 mg per day, which is part of why online protocols disagree so much about frequency.
AOD 9604 is an experimental peptide, not a proven weight-loss treatment. Anyone using it should keep cycles short, track results with objective measures, and reassess rather than drifting into indefinite daily use.
How AOD 9604 Compares With Other Peptides
| Compound | How it works | Typical frequency |
|---|---|---|
| AOD 9604 | hGH fragment that targets fat metabolism | Once or twice daily |
| Tesamorelin | GHRH analog that raises your own growth hormone | Once daily |
| MOTS-c | Mitochondrial peptide studied for metabolic effects | Once daily in research settings |
| Ipamorelin | Growth hormone secretagogue | Once or twice daily |
Combining aod 9604 with tesamorelin is a frequent topic because the two act on different parts of the same system: tesamorelin increases endogenous growth hormone output, while AOD 9604 delivers a fat-targeted fragment directly. In comparisons such as aod 9604 vs mots-c, the main difference is mechanism, since MOTS-c works on mitochondrial metabolism rather than lipolysis signaling.
Safety, Sourcing, and Storage
Reported side effects are usually mild and include injection-site redness, headache, and occasional nausea. The human trials were small and short, so long-term safety data in healthy adults simply does not exist.
AOD 9604 sold online is almost always labeled as a research chemical, which means the FDA does not verify its purity, identity, or sterility. Storage matters as well: if you are checking how long is bac water good for in the fridge, the common guidance is to use it within 28 days of the first puncture, and to keep lyophilized powder refrigerated and out of light.
Talk with a healthcare professional before starting AOD 9604, particularly if you take diabetes medication, have a thyroid condition, or are pregnant or breastfeeding.
Frequently Asked Questions
How often should you inject AOD 9604?
Most research protocols call for one subcutaneous injection per day, typically 300 mcg to 600 mcg taken in the morning while fasted. Some people split the same total dose into two smaller injections, one in the morning and one before bed. AOD 9604 is not FDA-approved, so there is no official dosing schedule.
Can you take AOD 9604 twice a day?
Yes, split dosing is a common variation, usually 150 mcg to 300 mcg twice daily. The goal is steadier exposure across the day, but no study has proven that twice-daily dosing works better than a single daily injection. Consistency and total daily dose matter more than the number of shots.
How long does AOD 9604 take to work?
Community reports usually describe noticeable changes after four to eight weeks, and clinical trials have run for roughly 12 weeks. Results vary widely, and later studies were less impressive than early ones. AOD 9604 is a research peptide, not a proven weight-loss drug, so expectations should stay modest.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.